Literature DB >> 6832555

Nitrofurantoin-induced pancreatitis: report of a case.

G F Nelis.   

Abstract

A patient with nitrofurantoin-induced pancreatitis is described, representing the first patient with this condition to be reported in the literature. The diagnosis of nitrofurantoin-induced pancreatitis was confirmed by rechallenge. The clinical and biochemical picture cleared rapidly after discontinuation of the drug. The conclusion is proffered that nitrofurantoin-induced jaundice is not always due to cholestatic hepatitis, but can result from obstruction of the common bile duct due to edema of the pancreatic head secondary to nitrofurantoin pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6832555

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

Review 1.  Drug-induced acute pancreatitis. A critical review.

Authors:  A K Banerjee; K J Patel; S L Grainger
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 May-Jun

2.  Pancreatitis induced by nitrofurantoin.

Authors:  J L Christophe
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

Review 3.  Drug-induced pancreatitis.

Authors:  T Wilmink; T W Frick
Journal:  Drug Saf       Date:  1996-06       Impact factor: 5.606

Review 4.  Drug-induced pancreatitis : incidence, management and prevention.

Authors:  Anil R Balani; James H Grendell
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 5.  Ever-increasing diversity of drug-induced pancreatitis.

Authors:  Simcha Weissman; Muhammad Aziz; Ryan B Perumpail; Tej I Mehta; Rutwik Patel; James H Tabibian
Journal:  World J Gastroenterol       Date:  2020-06-14       Impact factor: 5.742

6.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.